Skip to content

King Pharmaceuticals KG Unearned premiums

Unearned premiums at other companies

Arch Capital Group logo
Arch Capital GroupACGL
$10.94B-1.4%
Everest Group logo
Everest GroupEG
$6.7B-7.7%
SiriusPoint logo
SiriusPointSPNT
$1.99B+9.6%
Skyward Specialty Insurance Group, Inc. logo
Skyward Specialty Insurance Group, Inc.SKWD
$1.01B+43.2%
Selective Insurance Group logo
Selective Insurance GroupSIGI
$2.75B+2.1%
W.R. Berkley logo
W.R. BerkleyWRB
$6.78B+4.4%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-71.3%
Enterprise value$184.93M-52.3%
P/E1.2×
P/S1.6×-27.7×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:UnearnedPremiums.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's unearned premiums.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's unearned premiums?
King Pharmaceuticals (KG) reported unearned premiums of $16.89M in Q1 2026.
What does unearned premiums mean?
This represents the portion of insurance premiums collected in advance that corresponds to the unexpired period of the insurance policies. It is a liability because the company remains obligated to provide coverage for the remainder of the policy term. The movement in this balance indicates the growth or contraction of the company's active insurance business.